Last update Dec. 1, 2004

Mizolastine

Low Risk

Moderately safe. Probably compatible. Mild risk possible. Follow up recommended. Read the Comment.

It is a not sedative anti-histaminic drug without an anti-muscarinic activity. Avoid its use on patients affected of cardiac arrhythmia or along with erythromycin and/or ketoconazole o si el lactante está tomando un macrólido.

Alternatives

We do not have alternatives for Mizolastine.

Suggestions made at e-lactancia are done by APILAM team of health professionals, and are based on updated scientific publications. It is not intended to replace the relationship you have with your doctor but to compound it.

Jose Maria Paricio, Founder & President of APILAM/e-Lactancia

Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.

Thank you for helping to protect and promote breastfeeding.

José María Paricio, founder of e-lactancia.

Group

Mizolastine belongs to this group or family:

Tradenames

Main tradenames from several countries containing Mizolastine in its composition:

Pharmacokinetics

Variable Value Unit
Oral Bioavail. 65 %
Molecular weight 433 daltons
Protein Binding 98 %
Tmax 1.5 hours
13 hours

References

  1. del Cuvillo A, Mullol J, Bartra J, Dávila I, Jáuregui I, Montoro J, Sastre J, Valero AL. Comparative pharmacology of the H1 antihistamines. J Investig Allergol Clin Immunol. 2006;16 Suppl 1:3-12. Review. No abstract available. Abstract Full text (link to original source) Full text (in our servers)

Total visits

4,041

Help us improve this entry

How to cite this entry

Do you need more information or did not found what you were looking for?

   Write us at elactancia.org@gmail.com

e-lactancia is a resource recommended by IHAN of Spain

Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM